New HIV Drug Set To Cut Long-Term Side Effects Of Medication

Genvoya, a new anti-HIV drug that could drastically reduce long-term side effects, was given European Commission approval, allowing 28 countries in the EU to give it to HIV-positive patients. Trials show that Genvoya leads to reduced bone and kidney problems compared to current treatments. Via Buzzfeed News. Posted November 23, 2015.

–Alanna McCatty


Alanna M.

Alanna M. is a graduate of Pace University.


Did you find this article helpful?


Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…